Detalhe da pesquisa
1.
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults.
EClinicalMedicine
; 39: 101076, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430837
2.
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial.
Front Immunol
; 10: 335, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906291
3.
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.
Front Immunol
; 8: 1884, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29375556